Advances in reproductive health genetic research has led to the emergence of chromosomal microarray analysis (CMA), which has greatly expanded the capabilities of cytogenetics testing. CMA is an ideal platform for copy number variation (CNV) analysis and molecular cytogenetic research. It is a widely used genetic analysis tool, recommended by American College of Medical Genetics (ACMG) as a first-tier test for postnatal research of unexplained developmental delay, intellectual disability, congenital anomalies, and autism spectrum disorder.

Thermo Fisher Scientific offers reliable microarray solutions powered with robust workflows that cytogeneticists trust to improve yield, accuracy, and efficiency.

With reproducible results, accurate data interpretation and hands-on support, Thermo Fisher Scientific is your trusted partner from start to finish.